These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22699537)

  • 1. Language impairment in Huntington's disease.
    Azambuja MJ; Radanovic M; Haddad MS; Adda CC; Barbosa ER; Mansur LL
    Arq Neuropsiquiatr; 2012 Jun; 70(6):410-5. PubMed ID: 22699537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex language functions and subcortical mechanisms: evidence from Huntington's disease and patients with non-thalamic subcortical lesions.
    Chenery HJ; Copland DA; Murdoch BE
    Int J Lang Commun Disord; 2002; 37(4):459-74. PubMed ID: 12396844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation--a longitudinal follow-up study.
    Lemiere J; Decruyenaere M; Evers-Kiebooms G; Vandenbussche E; Dom R
    J Neurol; 2004 Aug; 251(8):935-42. PubMed ID: 15316797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HD-CAB: a cognitive assessment battery for clinical trials in Huntington's disease 1,2,3.
    Stout JC; Queller S; Baker KN; Cowlishaw S; Sampaio C; Fitzer-Attas C; Borowsky B;
    Mov Disord; 2014 Sep; 29(10):1281-8. PubMed ID: 25209258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic linguistic profile of spontaneous narrative speech in pre-symptomatic and early stage Huntington's disease.
    Hinzen W; Rosselló J; Morey C; Camara E; Garcia-Gorro C; Salvador R; de Diego-Balaguer R
    Cortex; 2018 Mar; 100():71-83. PubMed ID: 28859906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spoken language production in Huntington's and Parkinson's diseases.
    Murray LL
    J Speech Lang Hear Res; 2000 Dec; 43(6):1350-66. PubMed ID: 11193957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor dysfunction influence on executive functioning in manifest and premanifest Huntington's disease.
    Hart EP; Dumas EM; Schoonderbeek A; Wolthuis SC; van Zwet EW; Roos RA
    Mov Disord; 2014 Mar; 29(3):320-6. PubMed ID: 24500841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verbal fluency, naming and verbal comprehension: three aspects of language as predictors of cognitive impairment.
    Maseda A; Lodeiro-Fernández L; Lorenzo-López L; Núñez-Naveira L; Balo A; Millán-Calenti JC
    Aging Ment Health; 2014; 18(8):1037-45. PubMed ID: 24797556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Cognition and Cortical Excitability in Huntington's Disease.
    Kamble N; Netravathi M; Nagaraju BC; Lenka A; Kumar K; Sowmya V; Jain S; Pal PK
    Can J Neurol Sci; 2018 Mar; 45(2):176-181. PubMed ID: 29307324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive Dysfunction Contributes to Mobility Impairments in Huntington's Disease.
    Kloos AD; Kegelmeyer DA; Fritz NE; Daley AM; Young GS; Kostyk SK
    J Huntingtons Dis; 2017; 6(4):363-370. PubMed ID: 29254103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Language functions in Huntington's disease.
    Podoll K; Caspary P; Lange HW; Noth J
    Brain; 1988 Dec; 111 ( Pt 6)():1475-503. PubMed ID: 2974745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial letter and semantic category fluency in Alzheimer's disease, Huntington's disease, and progressive supranuclear palsy.
    Rosser A; Hodges JR
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57(11):1389-94. PubMed ID: 7964817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing cognitive function in patients with Huntington's disease from China: A cross-sectional clinical study.
    Cheng YF; Liu KC; Yang TM; Xiao Y; Jiang QR; Huang JX; Zhang S; Wei QQ; Ou RW; Li CY; Gu XJ; Burgunder JM; Shang HF
    Brain Behav; 2023 Nov; 13(11):e3258. PubMed ID: 37849450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Language disintegration in spontaneous speech in Huntington's disease: a more fine-grained analysis.
    Tovar A; Garí Soler A; Ruiz-Idiago J; Mareca Viladrich C; Pomarol-Clotet E; Rosselló J; Hinzen W
    J Commun Disord; 2020; 83():105970. PubMed ID: 32062158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing impairment of executive function and psychomotor speed in premanifest and manifest Huntington's disease gene-expansion carriers.
    Unmack Larsen I; Vinther-Jensen T; Gade A; Nielsen JE; Vogel A
    J Int Neuropsychol Soc; 2015 Mar; 21(3):193-202. PubMed ID: 25850430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-Motor Phenotype Relates to Neuropsychiatric and Cognitive Disorders in Huntington's Disease.
    Julayanont P; Heilman KM; McFarland NR
    Mov Disord; 2020 May; 35(5):781-788. PubMed ID: 31922295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bradykinesia in early Huntington's disease.
    Sánchez-Pernaute R; Künig G; del Barrio Alba A; de Yébenes JG; Vontobel P; Leenders KL
    Neurology; 2000 Jan; 54(1):119-25. PubMed ID: 10636136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating language comprehension in Alzheimer's disease: the use of the Token test.
    Paula JJ; Bertola L; Nicolato R; Moraes EN; Malloy-Diniz LF
    Arq Neuropsiquiatr; 2012 Jun; 70(6):435-40. PubMed ID: 22699541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive correlates of HVOT performance differ between individuals with mild cognitive impairment and normal controls.
    Jefferson AL; Wong S; Bolen E; Ozonoff A; Green RC; Stern RA
    Arch Clin Neuropsychol; 2006 Aug; 21(5):405-12. PubMed ID: 16893623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Addenbrooke's Cognitive Examination-Revised accurately detects cognitive decline in Huntington's disease.
    Begeti F; Tan AY; Cummins GA; Collins LM; Guzman NV; Mason SL; Barker RA
    J Neurol; 2013 Nov; 260(11):2777-85. PubMed ID: 23922130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.